Objective: To assess the feasibility of the future implementation of a recently published Belgian treat-to-target scoring in daily practice, we investigated to what extent Belgian dermatologists use metrics and take comorbidities into account in the follow-up of psoriasis patients.
Methods: Belgian dermatologists were addressed to fill out an online questionnaire in April 2020.
Results: A total of 149 dermatologists completed the survey. About 55% (n = 78) indicated to do a full-body examination during every visit. Psoriasis Area Severity Index (PASI) was the most frequently used clinical score: 25% (n = 35) and 61% (n = 87) indicated to use it every visit or sometimes (>1/year), respectively. The most frequently used patient-reported outcome scoring system was the Dermatology Life Quality Index: 35% use it sometimes. Overall, there is awareness for the association with metabolic syndrome.
Conclusion: Among tools for follow-up on moderate-to-severe psoriasis patients, Belgian dermatologists most frequently apply full-body examination and PASI score. Patient-reported outcome scoring systems are used infrequently. Psoriasis is perceived as a disease with comorbidities beyond the skin, especially obesity and hypertension. These real-world data on the use of clinical scores and PROs indicate a discrepancy from the academic setting in which new drugs are developed and evaluated. Furthermore, these data are imperative to estimate the feasibility of implementing a treat-to-target strategy published earlier by a Belgian expert group.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710531 | PMC |
| http://dx.doi.org/10.2147/PTT.S341215 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Belgian recommendations for managing psoriasis in a changing treatment landscape.
J Eur Acad Dermatol Venereol
October 2024
Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
Article Synopsis
- Targeted biologic drugs and small molecules have revolutionized psoriasis treatment, but their high cost presents a challenge for the Belgian healthcare system.
- Eight Belgian dermatologists conducted a quasi-Delphi initiative to evaluate current opportunities and challenges in psoriasis treatment, focusing on responsible and sustainable drug use.
- The update includes new treatment recommendations, insights on defining psoriasis severity, and the potential of teledermatology to enhance patient care while managing resources efficiently.
The role of community pharmacists in primary and secondary prevention of skin cancer: an evaluation of a Flemish skin cancer prevention campaign.
BMC Public Health
December 2023
Faculty of Pharmaceutical Sciences, Department of Bio-analysis, Pharmaceutical Care Unit, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Belgium.
Background: Skin cancer is a leading form of cancer in Belgium. Prevention of skin cancer by community pharmacists can play a role in increasing awareness and promoting sun protection. However, which persons could be reached by community pharmacists for skin cancer awareness in Belgium and whether this increased awareness is associated with increased sun protection and early detection remains unclear.
View Article and Find Full Text PDFCutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
JAMA Dermatol
August 2023
Service de Rhumatologie, Hôpital Cochin, AP-HP.CUP, Paris, France.
Importance: Systemic sclerosis (SSc) sine scleroderma (ssSSc) is a subset of SSc defined by the absence of skin fibrosis. Little is known about the natural history and skin manifestations among patients with ssSSc.
Objective: To characterize the clinical phenotype of patients with ssSSc compared with patients with limited cutaneous SSc (lcSSc) and diffuse cutaneous SSc (dcSSc) within the EUSTAR database.
Clinical and molecular diagnosis of genodermatoses: Review and perspectives.
J Eur Acad Dermatol Venereol
March 2023
Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Genodermatoses are a complex and heterogeneous group of genetic skin disorders characterized by variable expression and clinical and genetic heterogeneity, rendering their diagnosis challenging. DNA-based techniques, like whole-exome sequencing, can establish a diagnosis in 50% of cases. RNA-sequencing is emerging as an attractive tool that can obtain information regarding gene expression while integrating functional genomic data with regard to the interpretation of variants.
View Article and Find Full Text PDFDecision-making factors for the long-term topical treatment of mild-to-moderate plaque psoriasis: TEPPSO, a case-vignette study on clinical practice.
Ann Dermatol Venereol
March 2023
Dermatologie, Hôpital Charles Nicolle, Rouen, France.
Objectives: Topical maintenance therapy strategy with regard to patients with mild-to-moderate plaque psoriasis (PP) continues to be heterogeneous and insufficiently investigated in real-life clinical practice. The objective of this study was to describe the initiation of long-term maintenance treatment and to identify clinical parameters influencing the therapeutic decision.
Methods: TEPPSO was a French and Belgian multicentre cross-sectional study based on completion of questionnaires and assessment of credible clinical scenarios of mild-to-moderate PP by physicians using the validated case-vignette method.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!